If a vaccine is approved, will it be ethical to deny it to clinical trial participants?
Pfizer’s Covid-19 vaccine trial analysis that found the drug was 95% successful against the novel coronavirus
was conducted with 170 people confirmed to have the disease. Of them, however, 162 people were in the placebo group and only eight were in the vaccine arm.
On November 20, Pfizer
said it was asking the US Food and Drug Administration (FDA) for an emergency use authorisation (EUA) for its vaccine candidate. Once an EUA is granted, would it be ethical to deprive the vaccine to those who participated in the trial but received the placebo instead of the real thing? Read more here
Some patients face vision loss, blurry eyesight post-Covid. Doctors can’t confirm the link yet
Doctors say there are no large-scale studies so far to conclusively prove a connection between Covid-19 and vision problems, but many recovered patients have been reporting eye issues. A possible explanation offered for this phenomenon is that Covid infection has been linked to thrombosis or the emergence of clots in the body’s circulatory system. But, doctors urged caution and advise early intervention. Read more here
14% of symptomatic people traced in Delhi door-to-door survey not tested for Covid-19
Fourteen per cent of the people found symptomatic during the Delhi
government’s door-to-door survey over the past week were not tested for Covid-19. The Delhi government’s door-to-door survey for Covid-19 began Thursday last week. It was supposed to end Wednesday but it has now been extended following requests from some districts. Read more here
As Covid-19 impact continues, UP artisans are selling their goods online
The UP government's 'One District One Product' (ODOP) scheme is helping artisans move online. Launched in January 2018, ODOP is the state government's flagship programme. The objective is to preserve, develop and promote local arts, crafts, and traditional skills of communities spread across each district of Uttar Pradesh. The programme identifies small, local businesses and facilitates their training to enable them to improve their product quality and increase efficiency. Additionally, the programme aims to add to incomes and local employment, thus preventing migration due to the lack of employment opportunities. The programme also aims to revive traditional crafts. Read more here
After trial results of the AstraZeneca-Oxford vaccine, it has now emerged that a mistake in dosing led to the 90% efficacy report. What questions does this raise about this vaccine, and about trials in general? Read more here
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.